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Abstract: 
Objectives: Similar to cancer cells, the placenta has immunological and cellular 
characteristics. This study was conducted to evaluate the prophylactic antineoplastic 
property of placental lysate in chemical-induced hepatocellular carcinoma in C57BL/6 
mice. 
Methods: Lysate from a full-term human placenta was prepared following a standard 
protocol. The total protein concentration of the lysate was assessed. 18 male C57BL/6 
mice (3 weeks age, 8-10 g body weight) were used in the experiment and equally divided 
into 3 groups to receive the following treatments: Group 1: 20 μg placental lysate i.p. 
weekly for 3 consecutive weeks, followed by diethylnitrosamine (DEN) 75 mg/kg i.p. 
weekly from the 3
rd
 week for 4 consecutive weeks; Group 2: Normal saline (positive 
control) i.p. per mouse weekly for 3 consecutive weeks, followed by injection of DEN 75 
 
2 
mg/kg i.p. weekly from the 3
rd
 week for 4 consecutive weeks; Group 3: No intervention 
(negative control). Changes in body weight and mortality were recorded in all the 
animals. Histopathological and immunohistochemical examination (alpha fetoprotein 
expression) of livers were done to check for the development of hepatocellular 
carcinoma. 
Results: There was a significant reduction of body weight in both Group 1 (p=0.027) and 
2 (p=0.013) animals at the time of death than after administration of diethylnitrosamine. 
Significant improvement in survival was observed in Group 1 animals compared to 
Group 2 ones (p=0.043). However, hepatocellular carcinomas were detected in both 
Group 1 and 2 animals. 
Conclusion: Although prophylactic administration of placental lysate could not prevent 
hepatocellular carcinoma, it significantly improved survival in comparison to placebo.  
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